GeneThera, Inc. Company Review & Valuation GTHR

About GeneThera, Inc.

GeneThera, Inc., a biotechnology company, focuses on developing molecular diagnostic tests, therapeutics, and vaccines to control emerging diseases in animals and humans. The company develops specific assays for chronic wasting disease in elk and deer, and mad cow disease in cattle; diagnostics for E. coli in cattle; and Johne's disease in dairy cattle and bison. Its molecular diagnostic assays solutions use real time fluorogenic polymerase chain reaction technology to detect the presence of infectious disease from the blood of live animals. The company also develops therapeutic vaccines using RNA interference technology; and adenovirus and AAV-based recombinant DNA vaccines for zoonotic pathogens using PURIVAX technology. Its products include Herd Guard, a Johne's management solution; HerdCheck, a diagnostic product; HerdSafe, a purification and recombinant based DNA vaccine; and HerdSoft, a Web-based Johne's disease management solution. The company was founded in 1995 and is based in Denver, Colorado.

  • Biotechnology
  • Denver, Colorado
Primary Stock Exchange Listings

Ticker Symbol:

GTHR

OTC Markets
United States

Stock Price

Performance

Registration required

Please login or create a free account to view all available contents of this section.

Create Account

Health Check

Registration required

Please login or create a free account to view all available contents of this section.

Create Account

Financial Reports

Registration required

Please login or create a free account to view all available contents of this section.

Create Account

Similar Companies

↑ back to top